Literature DB >> 16821725

Comparison of antagonistic ability against enteropathogens by G+ and G- anaerobic dominant components of human fecal microbiota.

D A Gomes1, A M L Souza, R V Lopes, A C Nunes, J R Nicoli.   

Abstract

To confirm if anaerobic G+-components are those responsible for the function of colonization resistance, obligate anaerobic G+- and G- -bacteria from normal dominant microbiota of human feces were isolated from three successive collections and then used in in vitro assays for antagonism against two enteropathogenic bacteria. The production of inhibitory diffusible compounds was determined on supplemented BHI agar and MRS agar media for G- - and G+-bacteria, respectively. Salmonella enterica subsp. enterica serovar Typhimurium and Shigella sonnei were used as indicators. G+-bacteria presented a higher overall antagonistic frequency against both pathogenic bacteria (57 and 64 % for S. enterica serovar Typhimurium and S. sonnei, respectively) when compared to G+-microorganisms but with a quite elevated variation between volunteers (0-100 %) and collection samples (40-72 and 40-80 % for S. enterica sv. Typhimurium and S. sonnei, respectively). On the other hand, only three among 143 G- -isolates tested showed antagonistic activity. The results showed that, at least in vitro, obligate anaerobic G+-components of the dominant human fecal microbiota present a higher potential for antagonism against the enteropathogenic models tested than do G- -bacteria.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16821725     DOI: 10.1007/BF02932170

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.629


  24 in total

Review 1.  Screening of intestinal microflora for effective probiotic bacteria.

Authors:  D J O'Sullivan
Journal:  J Agric Food Chem       Date:  2001-04       Impact factor: 5.279

Review 2.  Bacterial cell-to-cell signaling in the gastrointestinal tract.

Authors:  James B Kaper; Vanessa Sperandio
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

3.  The Lactobacillus and Bifidobacterium microflora of the human intestine: composition and succession.

Authors:  G Reuter
Journal:  Curr Issues Intest Microbiol       Date:  2001-09

4.  Colonization pattern of the digestive tract by potentially pathogenic microorganisms: colonization-controlling mechanisms and consequences for antibiotic treatment.

Authors:  D van der Waaij
Journal:  Infection       Date:  1983       Impact factor: 3.553

Review 5.  Selective decontamination of the digestive tract.

Authors:  Wolfgang A Krueger; Klaus E Unertl
Journal:  Curr Opin Crit Care       Date:  2002-04       Impact factor: 3.687

6.  Identification of Lactobacillus isolates from the gastrointestinal tract, silage, and yoghurt by 16S-23S rRNA gene intergenic spacer region sequence comparisons.

Authors:  G W Tannock; A Tilsala-Timisjarvi; S Rodtong; J Ng; K Munro; T Alatossava
Journal:  Appl Environ Microbiol       Date:  1999-09       Impact factor: 4.792

7.  Molecular analysis of the composition of the bifidobacterial and lactobacillus microflora of humans.

Authors:  A L McCartney; W Wenzhi; G W Tannock
Journal:  Appl Environ Microbiol       Date:  1996-12       Impact factor: 4.792

8.  New medium for selection and presumptive identification of the Bacteroides fragilis group.

Authors:  S J Livingston; S D Kominos; R B Yee
Journal:  J Clin Microbiol       Date:  1978-05       Impact factor: 5.948

9.  Production of antibacterial substances by bifidobacterial isolates from infant stool active against Listeria monocytogenes.

Authors:  R Touré; E Kheadr; C Lacroix; O Moroni; I Fliss
Journal:  J Appl Microbiol       Date:  2003       Impact factor: 3.772

10.  Enumeration, isolation, and identification of bifidobacteria from infant feces.

Authors:  E Vlková; V Rada; D Bujnáková; V Kmet
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

View more
  3 in total

1.  Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection.

Authors:  Inna Sekirov; Nicola M Tam; Maria Jogova; Marilyn L Robertson; Yuling Li; Claudia Lupp; B Brett Finlay
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

2.  Therapeutic potential of different commercially available synbiotic on acetaminophen-induced uremic rats.

Authors:  Arpita Mandal; Arpita Patra; Shreya Mandal; Suchismita Roy; Shreya Das Mahapatra; Tapasi Das Mahapatra; Tanmay Paul; Koushik Das; Keshab Chandra Mondal; Dilip Kumar Nandi
Journal:  Clin Exp Nephrol       Date:  2014-04-17       Impact factor: 2.801

3.  Probiotic potential of enterococci isolated from canine feed.

Authors:  A Lauková; M Marcináková; V Strompfová; A C Ouwehand
Journal:  Folia Microbiol (Praha)       Date:  2008-05-15       Impact factor: 2.099

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.